Pancreatic Cancer Research

ResearcherCatholic University of KoreaActive in the last 2 years

Seung Bae Yoon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6119-7236; OpenAlex author ID A5049255506. Sources: OpenAlex.

Their work

Papers
16 (first author 9, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 6 papers · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 16

  1. Endoscopic ultrasound-guided tissue acquisition as a gateway to precision oncology in pancreatic cancer: current evidence and evolving clinical utility. First author DOI 10.5946/ce.2025.431↗
  2. Feasibility and clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling in pancreatic cancer: A systematic revi… Last author DOI 10.1016/j.pan.2024.12.012↗
  3. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing. First author DOI 10.3389/fonc.2024.1304187↗
  4. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Co-author DOI 10.1007/s00330-023-09959-5↗
  5. Evaluation of Perfusion Change According to Pancreatic Cancer and Pancreatic Duct Dilatation Using Free-Breathing Golden-Angle Radial Sparse Parallel (GRASP) M… First author DOI 10.3390/diagnostics13040731↗
  6. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. First author DOI 10.4251/wjgo.v15.i4.632↗
  7. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma. Co-author DOI 10.1007/s00330-022-08816-1↗
  8. ADC values from diffusion-weighted imaging may be lower for autoimmune pancreatitis than for pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.dld.2022.04.003↗
  9. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines10061289↗
  10. Sarcopenia in pancreatic cancer: Effect on patient outcomes. First author DOI 10.4251/wjgo.v14.i12.2302↗
  11. Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed … Co-author DOI 10.5009/gnl210123↗
  12. Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate… Co-author DOI 10.5009/gnl210123.e↗
  13. Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. First author DOI 10.1371/journal.pone.0240318↗
  14. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome. Co-author DOI 10.1007/s00261-018-1681-2↗
  15. Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer. First author DOI 10.1002/jcsm.12274↗
  16. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? First author DOI 10.1016/j.ejca.2018.08.027↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sung Woo Ko · 5 shared papers, 2022–2026 · strength 1.70
  2. Moon Hyung Choi · 9 shared papers, 2018–2024 · strength 1.60
  3. Tae Yeon Jeon · 3 shared papers, 2022–2023 · strength 0.66
  4. Sung‐Hoon Moon · 3 shared papers, 2022–2023 · strength 0.66
  5. Eun Sun Jung · 4 shared papers, 2018–2024 · strength 0.61
  6. Dongyeob Han · 2 shared papers, 2023–2024 · strength 0.51
  7. In Seok Lee · 4 shared papers, 2018–2022 · strength 0.46
  8. Myung Ah Lee · 4 shared papers, 2018–2022 · strength 0.46
  9. Tae Ho Hong · 4 shared papers, 2018–2022 · strength 0.46
  10. Sang Min Lee · 2 shared papers, 2022–2023 · strength 0.40
  11. Meiying Song · 3 shared papers, 2018–2020 · strength 0.29
  12. Tae Jun Song · 2 shared papers, 2022 · strength 0.26
  13. Seong‐Hun Kim · 2 shared papers, 2022 · strength 0.26
  14. Jun‐Ho Choi · 2 shared papers, 2022 · strength 0.26
  15. Sang Hyub Lee · 2 shared papers, 2022 · strength 0.26
  16. Jai Hoon Yoon · 2 shared papers, 2022 · strength 0.26
  17. Jae Hee Cho · 2 shared papers, 2022 · strength 0.26
  18. Dong‐Wan Seo · 2 shared papers, 2022 · strength 0.26
  19. Hoon Jai Chun · 2 shared papers, 2022 · strength 0.26
  20. Chang Min Cho · 2 shared papers, 2022 · strength 0.26
  21. Ho Joong Choi · 2 shared papers, 2018–2022 · strength 0.25
  22. Dominik Marcel Nickel · 1 shared paper, 2024 · strength 0.24
  23. Myung‐Hwan Kim · 1 shared paper, 2022 · strength 0.20
  24. Dong Woo Shin · 1 shared paper, 2023 · strength 0.19
  25. Min-Jeong Kim · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.